Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Panitsas · SciRah

Researcher profile · Semantic Scholar

F. Panitsas

Share profile

F. Panitsas — researcher profile on SciRah

h-index: 12
Works: 64
Citations: 675

Most-cited papers

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response.
F. Panitsas, M. Theodoropoulou, A. Kouraklis, M. Karakantza +4 more
2004Blood253 citations
Semantic Scholar
Expression patterns of leptin receptor (OB-R) isoforms and direct in vitro effects of recombinant leptin on OB-R, leptin expression and cytokine secretion by human hematopoietic malignant cells.
A. Mouzaki, Ioannis Panagoulias, Zoe Dervilli, V. Zolota +6 more
2009Cytokine35 citations
Semantic Scholar
Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
K. Manola, F. Panitsas, S. Polychronopoulou, A. Daraki +7 more
2013Cancer Genetics30 citations
Semantic Scholar
ASXL1 mutations in AML are associated with specific clinical and cytogenetic characteristics
Katerina Kakosaiou, F. Panitsas, A. Daraki, M. Pagoni +9 more
2018Leukemia and Lymphoma29 citations
Semantic Scholar
Syndrome of Inappropriate Secretion of Antidiuretic Hormone Associated with Imatinib
K. Liapis, J. Apostolidis, E. Charitaki, F. Panitsas +2 more
2008The Annals of Pharmacotherapy29 citations
Semantic Scholar
Long term outcomes in monoclonal gammopathy of renal significance
A. Khera, F. Panitsas, F. Djebbari, K. Kimberger +9 more
2019British Journal of Haematology26 citations Open access
Semantic Scholar
Outcomes and Characteristics of Non-Melanoma Skin Cancers in Patients with Myeloproliferative Neoplasms on Ruxolitinib.
Alexandros Rampotas, Luke Carter-Brzezinski, T. Somervaille, James Forryan +24 more
2023Blood24 citations
Semantic Scholar
Identification of Very Low-Risk Subgroups of Patients with Primary Mediastinal Large B-Cell Lymphoma Treated with R-CHOP.
T. Vassilakopoulos, M. Michail, S. Papageorgiou, G. Kourti +49 more
2021The Oncologist24 citations Open access
Semantic Scholar
Treat or palliate: outcomes of very elderly myeloma patients
F. Panitsas, Jaimal Kothari, G. Vallance, F. Djebbari +3 more
2018Haematologica21 citations Open access
Semantic Scholar
Expression of the novel tumour suppressor sterile alpha motif and HD domain‐containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma
I. Xagoraris, T. Vassilakopoulos, E. Drakos, M. Angelopoulou +6 more
2021British Journal of Haematology19 citations Open access
Semantic Scholar
Acute Promyelocytic Leukemia: an Experience on 95 Greek Patients Treated in the All-Trans-Retinoic Acid Era
M. Pagoni, M. Garofalaki, F. Panitsas, K. Manola +14 more
2011Mediterranean Journal of Hematology and Infectious Diseases16 citations Open access
Semantic Scholar
Testing and management for monoclonal gammopathy of uncertain significance and myeloma patients presenting with osteoporosis and fragility fractures.
G. Nador, K. Ramasamy, F. Panitsas, G. Pratt +2 more
2019Rheumatology13 citations Open access
Semantic Scholar
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era
T. Vassilakopoulos, F. Panitsas, Z. Mellios, J. Apostolidis +21 more
2022Hematological Oncology12 citations
Semantic Scholar
Efficacy of Isatuximab With Pomalidomide and Dexamethasone in Relapsed Myeloma: Results of a UK-Wide Real-World Dataset
F. Djebbari, Alexandros Rampotas, G. Vallance, F. Panitsas +24 more
2022HemaSphere11 citations Open access
Semantic Scholar
Prognostic Impact of Serum β2-Microglobulin Levels in Hodgkin Lymphoma Treated with ABVD or Equivalent Regimens: A Comprehensive Analysis of 915 Patients
T. Vassilakopoulos, M. Arapaki, P. Diamantopoulos, A. Liaskas +29 more
2024Cancers10 citations Open access
Semantic Scholar
Serum ferritin levels in previously untreated classical Hodgkin lymphoma: correlations and prognostic significance
S. Karakatsanis, F. Panitsas, M. Arapaki, D. Galopoulos +32 more
2022Leukemia and Lymphoma10 citations
Semantic Scholar
Evaluation of the frailty characteristics and clinical outcomes according to the new frailty-based outcome prediction model (Myeloma Risk Profile-MRP) in a UK real-world cohort of elderly newly diagnosed Myeloma patients
F. Djebbari, Alexandros Rampotas, F. Panitsas, W. Lim +14 more
2022PLoS ONE9 citations Open access
Semantic Scholar
Very late relapses in Hodgkin lymphoma treated with chemotherapy with or without radiotherapy: linear pattern and distinct prognostic factors
T. Vassilakopoulos, E. Kravvariti, F. Panitsas, M. Angelopoulou +26 more
2022Blood Cancer Journal9 citations Open access
Semantic Scholar
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care.
F. Djebbari, F. Panitsas, T. Eyre, Catherine Prodger +8 more
2020Haematologica9 citations Open access
Semantic Scholar
Effect of splenectomy on type-1/type-2 cytokine gene expression in a patient with adult idiopathic thrombocytopenic purpura (ITP)
F. Panitsas, A. Mouzaki
2004BMC Blood Disorders9 citations Open access
Semantic Scholar
Autoimmune Hemolytic Anemia with Myelodysplastic Features Followed by Bilateral Adrenal Non-Hodgkin Lymphoma: A Case Report and Review of the Literature
E. Terpos, S. Theocharis, F. Panitsas, Theodoros Philippidis +2 more
2004Leukemia and Lymphoma8 citations
Semantic Scholar
Real World Efficacy and Safety of Momelotinib for Myelofibrosis: Evaluation of a UK-Wide Study Confirms 40% Anaemia Response Rate in a Non-Clinical Trial Cohort
Alexandros Rampotas, Elena Torre, Luke Carter-Brzezinski, Andrea Duminuco +29 more
2024Blood6 citations
Semantic Scholar
Infections in relapsed myeloma patients treated with isatuximab plus pomalidomide and dexamethasone during the COVID-19 pandemic: Initial results of a UK-wide real-world study
F. Djebbari, Alexandros Rampotas, G. Vallance, F. Panitsas +25 more
2022Hematology6 citations Open access
Semantic Scholar
Climatic Indices as Markers of Table-Grapes Postharvest Quality: A prediction exercise
E. Anastasiou, G. Xanthopoulos, C. Templalexis, D. Lentzou +5 more
2022Smart Agricultural Technology6 citations Open access
Semantic Scholar
Adoptive immunotherapy via Donor lymphocyte infusions following allogeneic haematopoietic stem cell transplantation for Myelofibrosis: A real world, retrospective multi-centre study.
A. Rampotas, K. Sockel, F. Panitsas, C. Theuser +12 more
2023Transplantation and Cellular Therapy5 citations Open access
Semantic Scholar
DPACE‐based chemotherapy in the era of myeloma novel agents: A UK multicentre study
F. Djebbari, Kanchana De Abrew, B. Salhan, F. Panitsas +7 more
2020European Journal of Haematology5 citations
Semantic Scholar
Development of Classic Hodgkin Lymphoma after successful treatment of primary mediastinal large b-cell lymphoma: results from a well-defined database.
T. Vassilakopoulos, A. Piperidou, E. Hadjiharissi, A. Panteliadou +26 more
2020Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis5 citations
Semantic Scholar
Hevylite and Freelite Normalisation Is a Surrogate Marker for MRD Negativity Post-ASCT
Lauren Campbell, F. Panitsas, Supratik Basu, Francis Anyanu +3 more
20165 citations
Semantic Scholar
Serological normalisation as a surrogate marker for minimal residual disease negativity in multiple myeloma
Lauren Campbell, F. Panitsas, Supratik Basu, Francis A Anyanwu +3 more
2018British Journal of Haematology4 citations Open access
Semantic Scholar
The Combination of the Proteasome Inhibitor Bortezomib with Doxorubicin and Dexamethasone (PAD Regimen) as Front-Line Therapy In Newly Diagnosed, High-Risk Multiple Myeloma: Results of a Phase II Prospective Multicenter Study
I. Baltathakis, E. Terpos, S. Delimpasi, K. Liapis +7 more
20104 citations
Semantic Scholar
Venetoclax–Rituximab and Emerging Treatment Strategies After c-BTKi Exposure in Relapsed/Refractory CLL: A Real-World Cohort and Literature Overview
Maria Dimou, R. Fioretzaki, Calliope Zerzi, E. Konstantinou +17 more
2025Cancers3 citations
Semantic Scholar
Optimally Delivered R-da-EPOCH Versus R-CHOP-21 in Primary Mediastinal Large B-Cell Lymphoma: A Real-Life Comparison in a Single Academic Center
A. Piperidou, M. Angelopoulou, C. Chatzidimitriou, J. Asimakopoulos +16 more
2025Cancers3 citations
Semantic Scholar
Myeloma care adaptations in the UK during SARS‐CoV‐2 pandemic: Challenges and measurable outcomes
F. Djebbari, F. Panitsas, F. Sharpley, Alexandros Rampotas +5 more
2020European Journal of Haematology3 citations Open access
Semantic Scholar
Infection-related morbidity in a large study of transplant non-eligible newly diagnosed myeloma patients treated with UK standard of care
F. Djebbari, F. Panitsas, T. Eyre, Catherine Prodger +8 more
2020Haematologica3 citations Open access
Semantic Scholar
Belantamab Mafodotin Monotherapy for Multiply‐Relapsed Myeloma: A Retrospective Study From the United Kingdom and the Republic of Ireland
Edmund C R Watson, F. Djebbari, F. Panitsas, G. Vallance +23 more
2025eJHaem2 citations Open access
Semantic Scholar
Efficacy and tolerability of VCD chemotherapy in a UK real‐world dataset of elderly transplant‐ineligible newly diagnosed myeloma patients
Alexandros Rampotas, F. Djebbari, F. Panitsas, Charlotte Lees +14 more
2021European Journal of Haematology2 citations
Semantic Scholar
Myeloma clinical outcomes following the first wave of COVID‐19: results from the Thames Valley Cancer Alliance (UK)
F. Sharpley, Jemma Larham, Angus Haines, F. Djebbari +11 more
2020British Journal of Haematology2 citations Open access
Semantic Scholar
Isatuximab with Pomalidomide and Dexamethasone Provides Comparable Efficacy Outcomes in Frail Routine Care Myeloma Patients in a UK-Wide Cohort
Alexandros Rampotas, Alexandros Rampotas, G. Vallance, F. Panitsas +24 more
2022Blood1 citations Open access
Semantic Scholar
P114: Very late relapses in patients with Hodgkin Lymphoma occuring ≥5 years after initial treament with chemotherapy ± radiotherapy: Treatment strategies and prognostic factors for the outcome
T. Vassilakopoulos, A. Liaskas, G. Rizzuto, Argyrios Symeonidis +25 more
2022HemaSphere1 citations Open access
Semantic Scholar
Efficacy Outcomes of Isatuximab with Pomalidomide and Dexamethasone Are Comparable to (ICARIA-MM) Trial Data: Initial Results of a UK-Wide Real-World Study of Relapsed Myeloma Patients
F. Djebbari, G. Vallance, Nanda Basker, F. Panitsas +24 more
2021Blood1 citations Open access
Semantic Scholar
Long Term Outcomes in Monoclonal Gammopathy of Renal Significance (MGRS)
A. Khera, K. Kimberger, F. Panitsas, Jaimal Kothari +8 more
20171 citations
Semantic Scholar
Comparative Analysis of Cell Dose and Viability of Cord Blood Units at Cryopreservation and at Thaw/Infusion for Unrelated Stem Cell Transplantation in Adult Recipients
Spyridoula Vasileiou, I. Baltadakis, F. Panitsas, I. Tzannou +8 more
20141 citations Open access
Semantic Scholar
Ropeginterferon alfa-2b in mycosis fungoides: A multicentre cohort.
V. Nikolaou, Ioannis-Alexios Koumprentziotis, I. Konstantinou, Theodoros Iliakis +9 more
2026Journal of the European Academy of Dermatology and Venereology0 citations
Semantic Scholar
Focus on Extremely Late Relapses in Hodgkin Lymphoma: A Single Center Analysis
A. Liaskas, F. Panitsas, M. Angelopoulou, M. Siakantaris +2 more
2026Cancers0 citations Open access
Semantic Scholar
Outcomes for post-transplant relapsed acute lymphoblastic leukaemia in the era of novel therapies: A retrospective multicentre UK study.
A. Rampotas, A. Kirkwood, M. Brodermann, N. Maciocia +13 more
2026British Journal of Haematology0 citations Open access
Semantic Scholar
Validation of the simplified geriatric prognostic index in a Hellenic database of older patients (≥ 70 years old) with diffuse large B-cell lymphoma and similar disorders
T. Vassilakopoulos, F. Panitsas, M. Arapaki, A. Anastasopoulou +18 more
2025Annals of Hematology0 citations Open access
Semantic Scholar
Frailty subgroup analysis of isatuximab with pomalidomide and dexamethasone in a UK‐wide real‐world cohort of relapsed myeloma patients
F. Djebbari, Alexandros Rampotas, G. Vallance, F. Panitsas +26 more
2023British Journal of Haematology0 citations Open access
Semantic Scholar
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version
M. Belia, I. Drandakis, E. Lakiotaki, M. Arapaki +7 more
2023Annals of Hematology0 citations
Semantic Scholar
P-322 Real world outcomes of belantamab mafodotin from the UK and Ireland: updated results
Edmund C R Watson, F. Djebbari, F. Panitsas, G. Vallance +21 more
2023Clinical Lymphoma, Myeloma & Leukemia0 citations
Semantic Scholar
Symptomatic ovarian involvement as the initial presentation of primary mediastinal large b-cell lymphoma
A. Piperidou, I. Drandakis, M. Lefaki, E. Lakiotaki +8 more
2022Gynecologic Oncology Reports0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Ramasamy×20
Invite
K. Ramasamy — researcher profile on SciRah
F. Djebbari×15
Invite
F. Djebbari — researcher profile on SciRah
M. Angelopoulou×13
Invite
M. Angelopoulou — researcher profile on SciRah
Jaimal Kothari×11
Invite
Jaimal Kothari — researcher profile on SciRah

×11

Invite

G. Pangalis — researcher profile on SciRah

G. Vallance×11

Invite

G. Vallance — researcher profile on SciRah

Alexandros Rampotas×11

Invite

Alexandros Rampotas — researcher profile on SciRah

T. Vassilakopoulos×10

Invite

T. Vassilakopoulos — researcher profile on SciRah

M. Siakantaris×10

Invite

M. Siakantaris — researcher profile on SciRah

P. Panayiotidis×9

Invite

P. Panayiotidis — researcher profile on SciRah

Invite

A. Liaskas — researcher profile on SciRah

Invite

A. Khera — researcher profile on SciRah